Sustained activation of EGFR-ERK1/2 signaling limits the therapeutic response to tigecycline-induced inhibition of mitochondrial translation in liver cancer

Wenxin Qin(Shanghai Jiao Tong University), Haojie Jin(Shanghai Cancer Institute)
Research Square
March 25, 2022
Cited by 0


Related Papers